Table 1 Summary of the cohort characteristics at inclusion
From: Metabolic remodeling in glioblastoma: a longitudinal multi-omics study
Characteristics | Controls | Inclusion | p-value |
|---|---|---|---|
Agea | 59 (53–65) | 63 (56–66) | > 0.9 |
Sex | |||
Female | 14/33 (42%) | 15/34 (44%) | > 0.9 |
Male | 19/33 (58%) | 19/34 (56%) | |
Karnofksy score > 70 | 29/34 (85%) | ||
Obesity | 7/34 (21%) | ||
Diabetes | 7/34 (21%) | ||
Hypercholesterolemia | 8/34 (24%) | ||
Corticoids (mg/j) | 35 (0–40) | ||
Statin | 5/34 (15%) | ||
Metformin | 5/34 (15%) | ||
MGMT promoter methylation | 6/34 (18%) |